An emerging method of molecular analysis holds significant potential for profiling the tumors where the biomarkers originated, and thereby improving the diagnosis and treatment of cancer and other diseases.
Read More
CLP speaks with Antonia R. Sepulveda, MD, PhD, FASCP, FCAP, of Columbia University, about a forthcoming clinical practice guideline for the use of molecular marker testing in patients with primary or metastatic colorectal carcinoma.
Read More
Breast pathology experts share their views about a controversial JAMA study that has raised public anxiety and professional frustration.
Read More
Noninvasive liquid biopsy enables detection of emerging T790M mutations with greater sensitivity than tissue biopsy and months before detection of cancer progression with imaging.
Read More
An alternative to traditional screening methods, the LungFusion panel identifies expressed translocations of known clinical relevance in formalin-fixed, paraffin-embedded and fresh frozen tissue samples.
Read More